PRAX Praxis Precision Medicines, Inc
$334.58▼ -1.18%
Healthcare
Other
After hours
$334.50▼ -0.02%
Sep 11, 7:30 PM ET
Volume 173.5K
Avg Volume (10D) 273.1K
Key Metrics & Fundamentals
Market Cap
$9.34B
P/E Ratio
–
Div Yield
–%
52W Range
37.25 - 392.70
% vs 50 MA
-1.56%
% vs 200 MA
7.51%
RSI-14
42.3
MACD Histogram
-4.8000
Beta (1Y vs SPY)
0.39
Free Cash Flow
-$78.56M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$96.87M
COGS
–
Operating Exp
$96.90M
Operating Income
-$96.90M
EBIT
-$96.90M
Pretax Income
-$83.72M
Net Income
-$83.72M
EPS (Diluted)
-2.87
Price & Volume History
Loading chart…
Recent News
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire · Sep 3, 2026 8:01 PM
Praxis Precision Medicines Could Be Approaching 'Perfect Trifecta,' Oppenheimer Says
MT Newswires · Aug 17, 2026 3:21 PM
Praxis (PRAX) Q2 2026 Earnings Call Transcript
Motley Fool · Aug 13, 2026 4:29 PM
4 Biotech Stocks With Major Second-Half Pipeline Catalysts This Year
Zacks · Aug 11, 2026 2:01 PM
Is Praxis (PRAX) Trading Bigger Losses for Long-Run CNS Ambition With Its Cash War Chest?
Simply Wall St. · Aug 8, 2026 10:12 PM
RBC Adjusts PT on Praxis Precision Medicines to $462 From $449, Keeps Outperform Speculative Risk Rating
MT Newswires · Aug 7, 2026 1:19 PM
Deutsche Bank Adjusts Praxis Precision Medicines PT to $475 From $374, Maintains Buy Rating
MT Newswires · Aug 7, 2026 1:12 PM
Praxis Precision Medicines, Inc. Q2 2026 Earnings Call Summary
Moby · Aug 7, 2026 12:30 PM
Praxis Precision Medicines Q2 Earnings Call Highlights
MarketBeat · Aug 7, 2026 8:04 AM
Praxis Precision Medicines Inc (PRAX) (Q2 2026) Earnings Call Highlights: FDA Approvals on ...
GuruFocus.com · Aug 6, 2026 11:15 PM
Financial Overview - Income Statement
Quarterly
Dec 2024
See PRAX's money flow as a full page
Social Sentiment
Avg +0.80 · 1 posts
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.